Bio News
Verily Life Sciences, in collaboration with NVIDIA and the U.S. National Institutes of Health’s All of Us Research Program, has developed the first multimodal foundation model combining electronic health record (EHR) and genomic data. Jonathan Amar of Verily Data Science said integrating genetic risk scores with EHR data significantly improved the ability to identify people at high risk for type 2 diabetes. Verily named the model Forecast 1.0 and made it available to researchers worldwide through GitHub.
BIOBOOK TEAM
biobookmedia@biobook.co.krMinistry of Trade, Industry and Energy and Ministry of Food and Drug Safety Sign Agreement on AI Transformation and Global Competitiveness in Biotech
Paragon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos
Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%
BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial
Roche Signs $1.6 Billion Deal With China’s Rona for ALK7 Obesity Drug
Formycon and Zydus’ Keytruda Biosimilar Is First to Be Accepted for FDA Review
